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Integrating Current Analyses of the Breast Cancer 
Microbiome
Sidra Sohail, Michael Burns, PhD
Loyola University Chicago
Background & Research Questions
The microbiome is the collection of bacteria that reside in tissues, and in cancer it has been implicated in a 
variety of tissues [2]. The nature of it is such that there are specific microbial effects in carcinogenicity for the 
different tissues [2]. In terms of the breast tissue, it was previously thought that it was sterile; however, it is 
now known that breast tissue has a diverse microbial community where differences have been observed 
between healthy and tumor tissue [1; 2; 3]. Currently, in microbiome research, taxonomic databases have 
been massively expanded and cleaned allowing for more accurate and updated taxonomic assignment, 
where pipelines and databases account for unforeseen biases. This project will analyze data from four 
studies investigating the microbiota of breast tissue, which include the papers by Urbaniak et al. [1], Hieken et 
al. [2],  Xuan et al. [3], and Chan et al. [4]. Currently, I am in the process of analyzing data from the Urbaniak
paper and Hieken paper.
There are two questions our research will address:
1) How robust are the original findings to re-analysis with modern tools?






1. Urbaniak, C. et al. Microbiota of human breast tissue. Appl. 
Environ. Microbiol. 80, 3007–3014 (2014).
2. Hieken, T. J. et al. The Microbiome of Aseptically Collected 
Human Breast Tissue in Benign and Malignant Disease. Sci. Rep. 
6, 30751 (2016).
3. Xuan, C. et al. Microbial dysbiosis is associated with human breast 
cancer. PLoS One 9, e83744 (2014).
4. Chan, A. A. et al. Characterization of the microbiome of nipple 





Figure a): An abundance bar plot showing bacterial composition 
at the genus level from the DADA2 analysis of the Hieken data, 
which includes Aphagea, Bacillus, Choanozoa, Pectobacterium, 
Serratia, Streptococcus, and Streptophyta.
Figure b): An abundance bar plot showing bacterial 
composition at the genus level from the DADA2 analysis of the 
Urbaniak data, which includes Escherichia-Shigella, 
Flavobacterium, Lachnospiraceae NK3A20 group, 
Mesorhizobium, and Salmonella.
Figure c): An abundance bar plot from the original Hieken study 
showing bacterial composition of the benign and cancer 
samples at the Phylum, Family, and Genus levels.
Figure d): An abundance bar plot from the DADA2 analysis of 
the Hieken data showing bacterial abundance of the benign and 
cancer samples at the Phylum, Family, and Genus levels.
The bacterial taxa in Figures c) &  d) do not overlap at any 
taxonomic level, and do not contain any similarities.
Recent Findings, Next Steps, & Acknowledgements
Our current results show that our findings are different from the original studies. The bacterial 
abundance from our findings from the Hieken[2] and Urbaniak[1] data analysis differ from what 
is reported in the original respective papers. It is exciting to discover that our preliminary findings 
do not align with the original results, as this means that there are biological factors in the updated 
datasets (SILVA) that no one has explored yet.
The next steps are to analyze the Xuan[3] and Chan[4] data and run them through DADA2 and 
phyloseq, and implement an approach similar to what is stated in the Research Approach section.
I would like to thank Dr. Burns for his great mentorship, and guidance in implementing code. 
Generous funding was provided by the Burns Lab.
Abstract
This project integrates all available studies related to breast cancer and the mammary microbiome to 1) reassess 
the original findings in light of advances in this rapidly progressing field and 2) incorporate all the data available as 
a large meta-analysis to identify general trends and specific differences across patient cohorts and studies. In 
order to reassess original findings of each study, the 16S rRNA sequence data will be retrieved from SRA and 
analyzed using a bioinformatics pipeline, which will use an amplicon sequence variant. The results from the 
bioinformatics pipeline will be compared with the findings from the original studies. In order to identify specific 
trends and differences across patient cohorts and studies, I will compile the results from each of the available 
studies into a single dataset to assess for trends in microbial community interactions with breast cancer across 
studies. As different patient cohorts, 16S rRNA variable regions, and experimental protocols were used across the 
studies of interest, I will need to statistically account for these covariates in my model. The final ASV tables from 
the bioinformatics pipeline analysis for each study will be merged and assessed using multivariate analysis.
